Format

Send to:

Choose Destination
See comment in PubMed Commons below
Artif Intell Med. 2013 Mar;57(3):219-29. doi: 10.1016/j.artmed.2012.12.005. Epub 2013 Feb 1.

Predicting human immunodeficiency virus inhibitors using multi-dimensional Bayesian network classifiers.

Author information

  • 1Computational Intelligence Group, Departamento de Inteligencia Artificial, Facultad de Informática, Universidad Politécnica de Madrid, Boadilla del Monte 28660, Spain. hanen.borchani@upm.es

Abstract

OBJECTIVE:

Our aim is to use multi-dimensional Bayesian network classifiers in order to predict the human immunodeficiency virus type 1 (HIV-1) reverse transcriptase and protease inhibitors given an input set of respective resistance mutations that an HIV patient carries.

MATERIALS AND METHODS:

Multi-dimensional Bayesian network classifiers (MBCs) are probabilistic graphical models especially designed to solve multi-dimensional classification problems, where each input instance in the data set has to be assigned simultaneously to multiple output class variables that are not necessarily binary. In this paper, we introduce a new method, named MB-MBC, for learning MBCs from data by determining the Markov blanket around each class variable using the HITON algorithm. Our method is applied to both reverse transcriptase and protease data sets obtained from the Stanford HIV-1 database.

RESULTS:

Regarding the prediction of antiretroviral combination therapies, the experimental study shows promising results in terms of classification accuracy compared with state-of-the-art MBC learning algorithms. For reverse transcriptase inhibitors, we get 71% and 11% in mean and global accuracy, respectively; while for protease inhibitors, we get more than 84% and 31% in mean and global accuracy, respectively. In addition, the analysis of MBC graphical structures lets us gain insight into both known and novel interactions between reverse transcriptase and protease inhibitors and their respective resistance mutations.

CONCLUSION:

MB-MBC algorithm is a valuable tool to analyze the HIV-1 reverse transcriptase and protease inhibitors prediction problem and to discover interactions within and between these two classes of inhibitors.

Copyright © 2012 Elsevier B.V. All rights reserved.

PMID:
23375464
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk